Adenosinergic metabolism pathway: an emerging target for improving outcomes of solid organ transplantation
Translational Research · 2024
DOI: 10.1016/j.trsl.2023.09.002 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Translational Research, 2024. Verfasst von Bingran Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of liver surgery, Renji Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai Engineering Res…. Hauptthemen laut MEDLINE: Organ Transplantation, Reperfusion Injury. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 126 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Innovative research team of high-level local universities in Shanghai, Innovative Research Team of High-level Local University in Shanghai.
Abstract (Originalsprache)
Extracellular nucleotides are widely recognized as crucial modulators of immune responses in peripheral tissues. Adenosine triphosphate (ATP) and adenosine are key components of extracellular nucleotides, the balance of which contributes to immune homeostasis. Under tissue injury, ATP exerts its pro-inflammatory function, while the adenosinergic pathway rapidly degrades ATP to immunosuppressive adenosine, thus inhibiting excessive and uncontrolled inflammatory responses. Previous reviews have explored the immunoregulatory role of extracellular adenosine in various pathological conditions, especially inflammation and malignancy. However, current knowledge regarding adenosine and adenosinergic metabolism in the context of solid organ transplantation remains fragmented. In this review, we summarize the latest information on adenosine metabolism and the mechanisms by which it suppresses the effector function of immune cells, as well as highlight the protective role of adenosine in all stages of solid organ transplantation, including reducing ischemia reperfusion injury during organ procurement, alleviating rejection, and promoting graft regeneration after transplantation. Finally, we discuss the potential for future clinical translation of adenosinergic pathway in solid organ transplantation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of liver surgery, Renji Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai Engineering Research Center of Transplantation and Immunology, Shanghai, China; Shang…
- Center for Immune-Related Diseases at Shanghai Institute of Immunology, Department of Respiratory and Critical Care Medicine of Ruijin Hospital, Department of Immunology and Microbiology, Shanghai Jiao Tong University S…
Förderung
- National Natural Science Foundation of China
- Innovative research team of high-level local universities in Shanghai
- Innovative Research Team of High-level Local University in Shanghai
Zitieren
APA
Wang, B., Zhou, A., Pan, Q., Li, Y., Xi, Z., He, K., Li, D., Li, B., Liu, Y., Liu, Y., & Xia, Q. (2024). Adenosinergic metabolism pathway: an emerging target for improving outcomes of solid organ transplantation. Translational Research. https://doi.org/10.1016/j.trsl.2023.09.002
Vancouver
Wang B, Zhou A, Pan Q, Li Y, Xi Z, He K, et al. Adenosinergic metabolism pathway: an emerging target for improving outcomes of solid organ transplantation. Translational Research. 2024. doi:10.1016/j.trsl.2023.09.002
BibTeX
@article{Wang2024,
author = {Wang, Bingran and Zhou, Aiwei and Pan, Qi and Li, Yanran and Xi, Zhifeng and He, Kang and Li, Dan and Li, Bin and Liu, Yongbo and Liu, Yuan and Xia, Qiang},
title = {Adenosinergic metabolism pathway: an emerging target for improving outcomes of solid organ transplantation},
journal = {Translational Research},
year = {2024},
doi = {10.1016/j.trsl.2023.09.002}
}
EUVIMED